Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Clinical And Radiological Predictors of Pathological Response to Chemo-Immunotherapy in Surgically Resected Non-Small Cell Lung Cancer.

Created on 13 Nov 2026

Authors

Giorgio Cannone, Luigi Lione, Ester Rosa, Anna Michielin, Martina Visonà, Vincenzo Verzeletti, Alessandro Bonis, Marco De Silvestro, Giovanni Comacchio, Fiorella Calabrese, Giulia Pasello, Laura Bonanno, Chiara Giraudo, Dario Gregori, Marco Schiavon, Andrea Dell'Amore

Published in

Clinical lung cancer. Volume 27. Issue 10. Pages 51-57. Oct 13, 2026. Epub Oct 13, 2026.

Abstract

Chemo-immunotherapy has shifted the treatment paradigm for advanced non-small cell lung cancer (aNSCLC), improving complete pathological response (CPR) and radical resection rates. However, preoperative parameters to predict pathological response (PR) and tailor surgical strategy are lacking. This study aimed to develop an integrated clinico-radiological model to predict PR to neoadjuvant chemo-immunotherapy.
Pre-treatment contrast chest-CT radiomic features were integrated with clinical variables and PET-CT metabolic parameters. PR was classified as CPR, major pathological response (MPR), or non-response (NR). A multistep machine learning approach using penalized multinomial regression and a random forest (RF) classifier was developed and assessed via internal cross-validation and multiclass AUC.
We retrospectively evaluated 83 patients with aNSCLC undergoing neoadjuvant chemo-immunotherapy and surgery between 2017 and 2025 (18 excluded due to lack of contrast CT). Most patients (74%) were stage IIIA-IIIB; lobectomy was performed in 80%. Pathological examination revealed CPR in 41.5%, MPR in 26.2%, and NR in 32.3% of cases. The integrated clinical-radiomic RF model achieved good discrimination among PR categories, yielding a macro-averaged mean AUC of 0.82 (95% CI: 0.72-0.97). Radiomic texture features reflecting tumor heterogeneity emerged as the strongest predictors of PR.
Preoperative prediction of PR after neoadjuvant chemo-immunotherapy is feasible using routinely available CT scans and clinical data. This integrated model provides a practical framework for surgical stratification, directly impacting patient selection and operative planning in aNSCLC.

PMID:
43019771
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement